Randomized Efficacy and Safety Trial With Oral S 44819 After Recent Ischemic Cerebral Event. International, Multi-centre, Randomized, Doubleblind Placebo-controlled Phase II Study. (RESTORE BRAIN Study)
Phase of Trial: Phase II
Latest Information Update: 01 Feb 2018
At a glance
- Drugs S 44819 (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms RESTORE BRAIN
- Sponsors Servier
- 23 May 2017 Planned End Date changed from 1 Jul 2018 to 1 Sep 2018.
- 23 May 2017 Planned primary completion date changed from 1 Jul 2018 to 1 Sep 2018.
- 23 May 2017 Status changed from not yet recruiting to recruiting.